Zhejiang Dayang Biotech Group Co., Ltd. (003017) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Dayang Biotech Group Co., Ltd.

Why is Zhejiang Dayang Biotech Group Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 14.97% and Operating profit at 10.10% over the last 5 years

With a growth in Net Sales of 12.52%, the company declared Very Positive results in Mar 26

The company has declared positive results for the last 5 consecutive quarters
NET SALES(HY) At CNY 576.26 MM has Grown at 18.74%
ROCE(HY) Highest at 9.02%
RAW MATERIAL COST(Y) Fallen by -12.69% (YoY)

With ROE of 8.78%, it has a attractive valuation with a 1.52 Price to Book Value

Over the past year, while the stock has generated a return of 0.92%, its profits have risen by 35.9% ; the PEG ratio of the company is 0.5
At the current price, the company has a high dividend yield of 1.1

Underperformed the market in the last 1 year

The stock has generated a return of 0.92% in the last 1 year, much lower than market (China Shanghai Composite) returns of 21.43%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Dayang Biotech Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Dayang Biotech Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Dayang Biotech Group Co., Ltd.

4.42%

1.65

39.75%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.97%

EBIT Growth (5y)

10.10%

EBIT to Interest (avg)

10.37

Debt to EBITDA (avg)

0.12

Net Debt to Equity (avg)

0.04

Sales to Capital Employed (avg)

0.64

Tax Ratio

10.04%

Dividend Payout Ratio

48.95%

Pledged Shares

Institutional Holding

ROCE (avg)

5.61%

ROE (avg)

7.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.52

EV to EBIT

21.76

EV to EBITDA

15.20

EV to Capital Employed

1.50

EV to Sales

1.71

PEG Ratio

0.48

Dividend Yield

1.13%

ROCE (Latest)

6.90%

ROE (Latest)

8.78%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

NET SALES(HY)

At CNY 576.26 MM has Grown at 18.74%

ROCE(HY)

Highest at 9.02%

RAW MATERIAL COST(Y)

Fallen by -12.69% (YoY

CASH AND EQV(HY)

Highest at CNY 921.61 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 6.88 times

PRE-TAX PROFIT(Q)

Highest at CNY 34.71 MM

NET PROFIT(Q)

Highest at CNY 30.83 MM

EPS(Q)

Highest at CNY 0.38

-2What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 4.7 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.84 times

Here's what is working for Zhejiang Dayang Biotech Group Co., Ltd.

Net Sales

At CNY 576.26 MM has Grown at 18.74%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 34.71 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 30.83 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.38

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 921.61 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 6.88 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -12.69% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Dayang Biotech Group Co., Ltd.

Debt-Equity Ratio

Highest at 4.7 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 5.84 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio